EANS-Adhoc: Curanum AG / Results of Q1/ 2009

--------------------------------------------------------------------------------
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

quarterly report

15.05.2009

Ad hoc announcement

CURANUM presents Q1 report: occupancy stable in the first quarter

Occupancy across the Group was stable in the first quarter of
2009. Revenue amounted to EUR63.1 million in the quarter just
elapsed (previous year: EUR63.7 million). The key factors behind
this trend were, firstly, an approximately 1.5% higher occupancy
in the first quarter of 2008, and, secondly, around EUR0.7 million
of absent revenue compared with the 2008 leap year due to the fact
that there was one day less in February 2009.

The personnel expense rose to EUR32.1 million (previous year: EUR31.5
million), and the rental expense increased to EUR13.9 million
(previous year: EUR13.8 million). Earnings before interest, tax,
depreciation and amortization (EBITDA) fell from EUR7.9 million in
the first quarter of 2008 to EUR6.4 million in the first quarter of
2009. The EBITDA margin fell from 12.3% to 10.1% in the reporting
period just elapsed.

EBIT amounted to EUR4.0 million in the first quarter of 2009
(previous year: EUR5.5 million), and earnings after tax reduced to
EUR1.1 million (previous year: EUR2.2 million). Earnings per share
fell accordingly from EUR0.07 to EUR0.04 per share in the first
quarter of 2009.

Gross cash flow from operating activities (before changes in
provisions and working capital) fell only slightly, and amounted
to EUR4.2 million in the reporting period, compared with gross
cash flow of EUR4.7 million in the previous year. Taking changes in
provisions and working capital into account, cash flow from
operating activities totaled EUR2.6 million (previous year: EUR4.1
million).

Equity increased slightly from EUR66.6 million as of December 31,
2008 to EUR67.0 million as of the end of the first quarter of
2009. This corresponds to an equity ratio of 27.8%.

As far as the full 2009 financial year is concerned our budget
(excluding acquisitions) envisages revenue of EUR257 million to
EUR259 million, EBITDA of EUR27.5 million to EUR29.0 million, and
net profit of between EUR6.5 million and EUR8.5 million.

Munich, May 15, 2009

The Management Board

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Curanum AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Bettina Pöschl

Tel. +49(0)89-242065-69

E-Mail: bettina.poeschl@curanum.de

Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: SDAX, CDAX, Classic All Share, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / regulated dealing